VIRGINIA COMMONWEALTH UNIVERSITY
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vcu.edu
A Prospective Evaluation of Clinical Outcomes in Acute Ischemic Stroke After Endovascular Treatment w/Doppler
Not Applicable
Not yet recruiting
- Conditions
- Anterior Cerebral Artery SyndromeAcute Ischemic StrokeCardioembolic StrokeCongestive Heart FailureDiabetesAnterior Cerebral Artery StrokeCoronary Artery DiseaseVasogenic Cerebral Edema
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 100
- Registration Number
- NCT07013396
- Locations
- πΊπΈ
Virginia Commonwealth University, Richmond, Virginia, United States
FearLess in NeuroOncology
Recruiting
- Conditions
- Primary Malignant Brain TumorGlioblastoma (GBM)AstrocytomaOligodendrogliomaCaregiver
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 112
- Registration Number
- NCT06989086
- Locations
- πΊπΈ
Virginia Commonwealth University, Richmond, Virginia, United States
Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects
Phase 2
Recruiting
- Conditions
- Opioid Use DisorderOpioid UseInsomniaOrexin Antagonist
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-05-20
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 100
- Registration Number
- NCT06981195
- Locations
- πΊπΈ
VCU Institute for Drug and Alcohol Studies, Richmond, Virginia, United States
Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 33
- Registration Number
- NCT06966388
- Locations
- πΊπΈ
Virginia Commonwealth University, Richmond, Virginia, United States
A Single-session Intervention Adaptation of the Habit Framework for the Prevention of Eating Disorders
Not Applicable
Recruiting
- Conditions
- Eating Disorder Not Otherwise Specified
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 160
- Registration Number
- NCT06861608
- Locations
- πΊπΈ
Virginia Commonwealth University, Richmond, Virginia, United States
Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques
Not Applicable
Recruiting
- Conditions
- Mucosal ErosionGingival Recession
- First Posted Date
- 2025-03-24
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 42
- Registration Number
- NCT06892496
- Locations
- πΊπΈ
Virginia Commonwealth University, Richmond, Virginia, United States
Safety and Efficacy of LOw DOse COlchicine in Patients With STatin INTolerance: the LODOCO STINT Pilot Study
Phase 1
Recruiting
- Conditions
- Statin Adverse Reaction
- Interventions
- Drug: Low-dose colchicine at 0.5mg dailyOther: Placebo
- First Posted Date
- 2025-03-13
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 30
- Registration Number
- NCT06874192
- Locations
- πΊπΈ
Virginia Commonwealth University, Richmond, Virginia, United States
Psychobiological Responses Following Exercise and Brain Stimulation
Not Applicable
Recruiting
- Conditions
- Psychological
- First Posted Date
- 2025-03-13
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 29
- Registration Number
- NCT06874595
- Locations
- πΊπΈ
Virginia Commonwealth University, Richmond, Virginia, United States
The Impact of Chronic E-Cigarette Usage on Microvascular Health
Recruiting
- Conditions
- E-Cig Use
- First Posted Date
- 2025-03-06
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 44
- Registration Number
- NCT06860698
- Locations
- πΊπΈ
Virginia Commonwealth University, Richmond, Virginia, United States
Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+
Phase 2
Recruiting
- Conditions
- Diffuse Large B-cell LymphomaDLBCL - Diffuse Large B Cell Lymphoma
- Interventions
- First Posted Date
- 2025-02-26
- Last Posted Date
- 2025-06-02
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 21
- Registration Number
- NCT06846463
- Locations
- πΊπΈ
Virginia Commonwealth University, Richmond, Virginia, United States